Annual SG&A
$23.80 M
+$7.42 M+45.27%
31 December 2023
Summary:
SAB Biotherapeutics annual selling, general & administrative expenses is currently $23.80 million, with the most recent change of +$7.42 million (+45.27%) on 31 December 2023. During the last 3 years, it has risen by +$17.03 million (+251.42%). SABS annual SG&A is now at all-time high.SABS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.48 M
-$164.00 K-4.50%
30 September 2024
Summary:
SAB Biotherapeutics quarterly selling, general & administrative expenses is currently $3.48 million, with the most recent change of -$164.00 thousand (-4.50%) on 30 September 2024. Over the past year, it has increased by +$908.00 thousand (+35.32%). SABS quarterly SG&A is now -76.62% below its all-time high of $14.88 million, reached on 31 December 2023.SABS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$400.35 M
-$45.57 M-12.84%
30 September 2024
Summary:
SAB Biotherapeutics TTM selling, general & administrative expenses is currently -$400.35 million, with the most recent change of -$45.57 million (-12.84%) on 30 September 2024. Over the past year, it has dropped by -$412.15 million (-3492.58%). SABS TTM SG&A is now -3240.61% below its all-time high of $26.19 million, reached on 30 September 2024.SABS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.3% | +35.3% | -3492.6% |
| 3 y3 years | +251.4% | -3.4% | -4390.5% |
| 5 y5 years | - | - | - |
SABS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +251.4% | -76.6% | +35.3% | -1050.6% | at low |
| 5 y | 5 years | at high | +481.1% | -76.6% | +45.0% | -3240.6% | at low |
| alltime | all time | at high | +481.1% | -76.6% | +45.0% | -3240.6% | at low |
SAB Biotherapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.48 M(-4.5%) | $26.19 M(+3.6%) |
| June 2024 | - | $3.64 M(-13.0%) | $25.28 M(+3.0%) |
| Mar 2024 | - | $4.19 M(-71.8%) | $24.54 M(+3.1%) |
| Dec 2023 | $23.80 M(+45.3%) | $14.88 M(+478.9%) | $23.80 M(+101.7%) |
| Sept 2023 | - | $2.57 M(-11.4%) | $11.80 M(-11.1%) |
| June 2023 | - | $2.90 M(-15.9%) | $13.27 M(-9.6%) |
| Mar 2023 | - | $3.45 M(+19.6%) | $14.68 M(-10.6%) |
| Dec 2022 | $16.38 M | $2.88 M(-28.7%) | $16.42 M(-22.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $4.04 M(-6.1%) | $21.29 M(+2.1%) |
| June 2022 | - | $4.31 M(-16.9%) | $20.85 M(+10.1%) |
| Mar 2022 | - | $5.19 M(-33.1%) | $18.94 M(+10.9%) |
| Dec 2021 | $17.09 M(+152.3%) | $7.75 M(+115.4%) | $17.09 M(+83.1%) |
| Sept 2021 | - | $3.60 M(+50.1%) | $9.33 M(+62.8%) |
| June 2021 | - | $2.40 M(-28.0%) | $5.73 M(+72.0%) |
| Mar 2021 | - | $3.33 M | $3.33 M |
| Dec 2020 | $6.77 M(+65.4%) | - | - |
| Dec 2019 | $4.10 M | - | - |
FAQ
- What is SAB Biotherapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual SG&A year-on-year change?
- What is SAB Biotherapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly SG&A year-on-year change?
- What is SAB Biotherapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for SAB Biotherapeutics?
- What is SAB Biotherapeutics TTM SG&A year-on-year change?
What is SAB Biotherapeutics annual selling, general & administrative expenses?
The current annual SG&A of SABS is $23.80 M
What is the all time high annual SG&A for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual selling, general & administrative expenses is $23.80 M
What is SAB Biotherapeutics annual SG&A year-on-year change?
Over the past year, SABS annual selling, general & administrative expenses has changed by +$7.42 M (+45.27%)
What is SAB Biotherapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of SABS is $3.48 M
What is the all time high quarterly SG&A for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly selling, general & administrative expenses is $14.88 M
What is SAB Biotherapeutics quarterly SG&A year-on-year change?
Over the past year, SABS quarterly selling, general & administrative expenses has changed by +$908.00 K (+35.32%)
What is SAB Biotherapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of SABS is -$400.35 M
What is the all time high TTM SG&A for SAB Biotherapeutics?
SAB Biotherapeutics all-time high TTM selling, general & administrative expenses is $26.19 M
What is SAB Biotherapeutics TTM SG&A year-on-year change?
Over the past year, SABS TTM selling, general & administrative expenses has changed by -$412.15 M (-3492.58%)